ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
…, T Bradbury, G Brusselle, C Cadus… - European …, 2022 - Eur Respiratory Soc
Clinical trials evaluating the management of acute exacerbations of COPD assess heterogeneous
outcomes, often omitting those that are clinically relevant or more important to patients…
outcomes, often omitting those that are clinically relevant or more important to patients…
[HTML][HTML] Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol
…, A Bikov, T Bradbury, G Brusselle, C Cadus… - ERJ open …, 2020 - Eur Respiratory Soc
Randomised controlled trials (RCTs) on the management of COPD exacerbations evaluate
heterogeneous outcomes, often omitting those that are clinically important and patient …
heterogeneous outcomes, often omitting those that are clinically important and patient …
Adherence to GOLD recommendations among Swiss pulmonologists and general practitioners
JL Marmy, JP Diedrich, C Cadus… - COPD: Journal of …, 2020 - Taylor & Francis
Significant variability in adherence to COPD management recommendations has been
reported. We aimed to evaluate real-life COPD pharmacotherapy prescribing patterns and …
reported. We aimed to evaluate real-life COPD pharmacotherapy prescribing patterns and …
Inhalative Therapie bei COPD und Asthma
…, P Grendelmeier, C Cadus - Therapeutische …, 2019 - econtent.hogrefe.com
Die inhalative Therapie ist nach wie vor sowohl bei der COPD als auch beim Asthma eine
wichtige Säule der Behandlung. Bei Asthma Patienten stehen primär die inhalativen …
wichtige Säule der Behandlung. Bei Asthma Patienten stehen primär die inhalativen …
Development of inhaled therapies for COPD and asthma
…, A Tschacher, P Grendelmeier, C Cadus - Therapeutische …, 2019 - europepmc.org
Development of inhaled therapies for COPD and asthma Abstract. Inhaled therapies still
represent one of the most important pillars of the COPD and asthma treatments. In recent years, …
represent one of the most important pillars of the COPD and asthma treatments. In recent years, …
Seltene Komplikation einer häufigen Erkrankung: Schilddrüse und epileptische Anfälle
C Cadus, A Mehlig, A Minder - Praxis, 2018 - econtent.hogrefe.com
Die Myxödemkrise ist eine lebensbedrohliche Komplikation einer nicht oder unzureichend
behandelten Hypothyreose (Mortalität 20–25%). Die Diagnosestellung erfolgt anhand der …
behandelten Hypothyreose (Mortalität 20–25%). Die Diagnosestellung erfolgt anhand der …
Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland
A Tschacher, C Cadus, S Schildge… - Current Medical …, 2021 - Taylor & Francis
Objective The aims of the survey were to assess first experiences of Swiss COPD patients
switching from the disposable to the new reusable Respimat inhaler, and to evaluate …
switching from the disposable to the new reusable Respimat inhaler, and to evaluate …
Predictors for treatment changes in COPD–A Swiss Cohort Study
…, NA Hussein, PO Bridevaux, C Cadus… - 2020 - Eur Respiratory Soc
Introduction: Chronic obstructive pulmonary disease (COPD) is a widely spread chronic
disease. In Switzerland, it is estimated that 400’000 patients suffer from COPD and 65million …
disease. In Switzerland, it is estimated that 400’000 patients suffer from COPD and 65million …
Rare Complication of a Common Disease: Thyroid and Epileptic Seizures
C Cadus, A Mehlig, A Minder - Praxis, 2018 - europepmc.org
Rare Complication of a Common Disease: Thyroid and Epileptic Seizures Abstract. A
myxedema crisis is a life-threatening complication of hypothyroidism (mortality 20-25%). The …
myxedema crisis is a life-threatening complication of hypothyroidism (mortality 20-25%). The …
[CITATION][C] Halbautomatisierte computerunterstützte Segmentierung von Tumoren des Kopf-Hals-Bereiches: eine genaue und zeitsparende Methode zur …
CF Cadus - 2015 - Johann Wolfgang-Goethe …